Researchers have achieved what once sounded like science fiction: using engineered nanoparticles to restore brain function in ...

New research suggests Alzheimer’s may start far earlier than previously thought, driven by a hidden toxic protein in the brain. Scientists found that an experimental drug, NU-9, blocks this early ...

An experimental drug developed at Northwestern University has demonstrated further promise as an early intervention for ...

Explore the potential of experimental drug NU-9 in early Alzheimer's intervention, targeting toxic amyloid beta forms.

The findings add to previous research at CU Anschutz which found that Alzheimer’s patients given Leukine showed improvement ...

Quanterix Corporation (NASDAQ: QTRX), a company transforming healthcare by accelerating biomarker breakthroughs from ...

A new drug being developed by scientists at Northwestern University may offer an exciting way to slow down or prevent ...

A new study identifies certain neurotoxins responsible for brain inflammation common to early on-set Alzheimer's disease and ...

Northwestern University scientists are developing an experimental drug that could serve as an early intervention for Alzheimer’s disease.

People given the herpes medication valacyclovir actually experienced worse cognitive decline than those given a placebo.

New research, published in Nature, has provided the first ever population-based data on the frequency of Alzheimer's disease ...

A pioneering study indicates that Alzheimer’s disease is considerably more widespread among individuals over 85 than previously believed. The research also found that over one in ten people aged 70 ...